BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Biotechnology and Pharmaceutical ChannelMedical Device and Diagnostics ChannelClinical Research Channel
APRICUS BIOSCIENCES (NQ: APRI)
3.240 USD  +0.220 (+7.28%)
Official Closing Price  /  Updated: 8:10 PM EDT, May 17, 2013  /  Add to My Watchlist      
(APRI) Community Analysis from
Bulls REASONS TO BUY
Bears REASONS TO SELL
May 18, 2013
(Benzinga, 9/29/10)
The markets are flat on the day, but three particular stocks have severely underperformed today, due to weak earnings, insider scandals and raising money. These are the three biggest losers on the NASDAQ today on a percentage basis,...(read more)
(Benzinga, 9/29/10)
Apricus Biosciences (Nasdaq: APRI) today announced that it has entered into agreements with selected investors to sell up to 1,728,882 Units at a price per Unit of $5.40, for aggregate gross proceeds of approximately $9.3 million....(read more)
Apricus Bioscience Inc (APRI) Company Overview

There is no analysis for APRI yet. But you can go to Wikinvest to help create one!


Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here